Raleigh, NC · Founded 2021 · Privately Held (backing)
Developer of advanced therapeutics designed to address unmet needs in the management of late-stage chronic kidney diseases. Pathalys Pharma is based in Raleigh, NC and was founded in 2021. Its last known valuation is $295 million. It has raised $266 million.
Last price · $/share
—
Implied valuation
$295.0M
Total raised
$266.0M
Last round
—
Team — not yet on record
No current team members for Pathalys Pharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Pathalys Pharma with a free account
·The complete investor list: 12 names
·Watch Pathalys Pharma: the Monday email on marks, rounds and moves
